Patent 10907125 was granted and assigned to Inscripta on February, 2021 by the United States Patent and Trademark Office.
The present disclosure provides a flow-through electroporation device configured for use in an automated multi-module cell processing environment and configured to decrease cell processing time and the risk of clogging.